{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:51:45Z","timestamp":1793713905402,"version":"4.6.1"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>To summarize the current understanding of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) throughout the rheumatoid arthritis (RA) disease course from preclinical to established disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>ILD is a serious extra-articular manifestation of RA. Multiple studies have demonstrated a high prevalence of both subclinical and clinical ILD throughout the RA disease course. Investigations of patients without RA have demonstrated an association between RA-related autoantibodies like anticitrullinated protein antibodies (ACPA) and interstitial abnormalities on lung imaging. A significant proportion of RA-ILD patients develop ILD prior to articular manifestations, suggesting that the lung plays a central role in RA development, perhaps through ACPA production. RA-ILD also occurs in early RA, when exuberant autoantibody production and systemic inflammation may propagate pulmonary disease activity. In patients with established RA, a high burden of subclinical and clinical ILD results in significant morbidity, mortality, and healthcare expenditure. Multiple epidemiologic and genetic risk factors, as well as serum biomarkers, have been associated with RA-ILD.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Subclinical and clinical ILD occur frequently in preclinical, early, and established RA and may play a key role in RA-related autoantibody production and disease progression. Further studies are needed to better understand the risk factors, prognosis, and potential therapies for RA-ILD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000787","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T05:34:19Z","timestamp":1614404059000},"page":"284-291","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":65,"title":["Interstitial lung disease throughout the rheumatoid arthritis disease course"],"prefix":"10.1097","volume":"33","author":[{"given":"Gregory C.","family":"McDermott","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J.","family":"Doyle","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Sparks","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital"},{"name":"Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1513\/pats.200703-045MS","article-title":"Rheumatoid lung disease","volume":"4","author":"Brown","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"R2-20250526","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted county, Minnesota, in 1995\u20132007 versus 1985\u20131994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J Rheumatol"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/BOR.0000000000000705","article-title":"Inhalants other than personal cigarette smoking and risk for developing rheumatoid arthritis","volume":"32","author":"Prisco","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R5-20250526","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/1744666X.2019.1698293","article-title":"Obstructive lung diseases and risk of rheumatoid arthritis","volume":"16","author":"Friedlander","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-019-0275-x","article-title":"Mechanisms of lung disease development in rheumatoid arthritis","volume":"15","author":"Wang","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2009.120899","article-title":"Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke","volume":"70","author":"K\u00e4llberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/ard.2009.114694","article-title":"Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis","volume":"69","author":"Stolt","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","article-title":"Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease","volume":"65","author":"Willis","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R11-20250526","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","article-title":"Structural changes and antibody enrichment in the lungs are early features of anticitrullinated protein antibody-positive rheumatoid arthritis","volume":"66","author":"Reynisdottir","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-015-3025-8","article-title":"Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis","volume":"34","author":"Restrepo","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.2.4583.816","article-title":"\u2018Rheumatoid disease\u2019 with joint and pulmonary manifestations","volume":"2","author":"Ellman","year":"1948","journal-title":"Br Med J"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rdc.2014.12.004","article-title":"Lung disease in rheumatoid arthritis","volume":"41","author":"Yunt","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00296-017-3781-7","article-title":"Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis","volume":"37","author":"Kim","year":"2017","journal-title":"Rheumatol Int"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/acr.23820","article-title":"Impact of cyclic citrullinated peptide antibody level on progression to rheumatoid arthritis in clinically tested cyclic citrullinated peptide antibody-positive patients without rheumatoid arthritis","volume":"71","author":"Ford","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/thoraxjnl-2016-208932","article-title":"Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the multi-ethnic study of atherosclerosis","volume":"71","author":"Bernstein","year":"2016","journal-title":"Thorax"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chest.2019.12.005","article-title":"IgA antibodies directed against citrullinated protein antigens are elevated in patients with idiopathic pulmonary fibrosis","volume":"157","author":"Solomon","year":"2020","journal-title":"Chest"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"issue":"(Suppl 1)","key":"R24-20250526","first-page":"A25.1","article-title":"Lung abnormalities in subjects with elevations of rheumatoid arthritis-related autoantibodies without arthritis by examination and imaging suggest the lung is an early and perhaps initiating site of inflammation in rheumatoid arthritis","volume":"71","author":"Demoruelle","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R25-20250526","first-page":"00633","article-title":"Duration of rheumatoid arthritis and the risk of developing interstitial lung disease","volume":"7","author":"Mohning","year":"2020","journal-title":"ERJ Open Res"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","article-title":"A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality","volume":"76","author":"Hyldgaard","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10067-017-3561-5","article-title":"Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease","volume":"36","author":"Zhang","year":"2017","journal-title":"Clin Rheumatol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12016-020-08819-0","article-title":"Distinctive clinical characteristics and outcome of ILD-onset rheumatoid arthritis and ACPA-positive ILD: a longitudinal cohort of 282 cases","volume":"60","author":"Chen","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"(2 I)","key":"R30-20250526","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s100670050160","article-title":"Prevalence of pulmonary disorders in patients with newly diagnosed rheumatoid arthritis","volume":"19","author":"Doyle","year":"2000","journal-title":"Clin Rheumatol"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10067-010-1492-5","article-title":"Pulmonary involvement in early rheumatoid arthritis patients","volume":"30","author":"Habib","year":"2011","journal-title":"Clin Rheumatol"},{"key":"R33-20250526","first-page":"1513","article-title":"Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis","volume":"35","author":"Mori","year":"2008","journal-title":"J Rheumatol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurjrheum.2019.19044","article-title":"Interstitial lung abnormalities in patients with early rheumatoid arthritis: a pilot study evaluating prevalence and progression","volume":"6","author":"Dong","year":"2019","journal-title":"Eur J Rheumatol"},{"issue":"(Suppl 1)","key":"R35-20250526","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/annrheumdis-2020-eular.1189","article-title":"Examination of interstitial lung disease in patients with rheumatoid arthritis \u2013 prevalence, time to onset, and clinical characteristics [abstract]","volume":"79","author":"Zhou","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R36-20250526","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R37-20250526","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11926-016-0563-2","article-title":"The roles of cigarette smoking and the lung in the transitions between phases of preclinical rheumatoid arthritis","volume":"18","author":"Sparks","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"R38-20250526","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis\u2014a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R39-20250526","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/rheumatology\/kez177","article-title":"The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment","volume":"58","author":"Duarte","year":"2019","journal-title":"Rheumatology"},{"key":"R40-20250526","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keaa836","article-title":"Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients","author":"Sparks","year":"2021","journal-title":"Rheumatology"},{"key":"R41-20250526","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R42-20250526","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semarthrit.2020.08.015","article-title":"Rheumatoid arthritis-related lung disease detected on clinical chest computed tomography imaging: prevalence, risk factors, and impact on mortality","volume":"50","author":"Huang","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"R43-20250526","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.chest.2020.04.061","article-title":"Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis","volume":"158","author":"Kawano-Dourado","year":"2020","journal-title":"Chest"},{"key":"R45-20250526","first-page":"1","article-title":"Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of U.S. veterans","volume":"115458","author":"Natalini","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"R46-20250526","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10067-019-04846-1","article-title":"A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease","volume":"39","author":"Li","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R47-20250526","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"(Suppl 10)","key":"R48-20250526","article-title":"High lung attenuation measured with quantitative densitometry as a surrogate marker for interstitial lung disease in RA: association with anti-CCP, smoking, and absence of shared epitope [abstract]","volume":"71","author":"Alevizos","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R49-20250526","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"R50-20250526","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3899\/jrheum.171315","article-title":"Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J Rheumatol"},{"key":"R51-20250526","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"key":"R52-20250526","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/resp.12234","article-title":"Predictors of mortality in rheumatoid arthritis-related interstitial lung disease","volume":"19","author":"Assayag","year":"2014","journal-title":"Respirology"},{"key":"R53-20250526","first-page":"344","article-title":"Patterns of interstitial lung disease and mortality in rheumatoid arthritis","volume":"56","author":"Zamora-Legoff","year":"2017","journal-title":"Rheumatology"},{"key":"R54-20250526","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"key":"R55-20250526","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1378\/chest.09-0444","article-title":"Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern","volume":"136","author":"Kim","year":"2009","journal-title":"Chest"},{"key":"R56-20250526","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.39971","article-title":"Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease","volume":"69","author":"Zamora-Legoff","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R57-20250526","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semarthrit.2019.04.005","article-title":"Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"49","author":"Singh","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"R58-20250526","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1378\/chest.13-1394","article-title":"Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis","volume":"146","author":"Doyle","year":"2014","journal-title":"Chest"},{"key":"R59-20250526","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/BOR.0000000000000703","article-title":"Management issues in rheumatoid arthritis-associated interstitial lung disease","volume":"32","author":"England","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"R60-20250526","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.2016.0518","article-title":"Association between interstitial lung abnormalities and all-cause mortality","volume":"315","author":"Putman","year":"2016","journal-title":"JAMA"},{"key":"R61-20250526","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: Current update on prevalence, risk factors, and pharmacologic treatment","volume":"6","author":"Huang","year":"2020","journal-title":"Curr Treat Options Rheumatol"},{"key":"R62-20250526","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"key":"R63-20250526","doi-asserted-by":"crossref","first-page":"e33133","DOI":"10.1371\/journal.pone.0033133","article-title":"Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope","volume":"7","author":"Furukawa","year":"2012","journal-title":"PLoS One"},{"key":"R64-20250526","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3899\/jrheum.101261","article-title":"High levels of anticyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis","volume":"38","author":"Aubart","year":"2011","journal-title":"J Rheumatol"},{"key":"R65-20250526","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology"},{"key":"R66-20250526","first-page":"1","article-title":"Anticyclic citrullinated peptide antibody is associated with interstitial lung disease in patients with rheumatoid arthritis","volume":"9","author":"Yin","year":"2014","journal-title":"PLoS One"},{"key":"R68-20250526","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3899\/jrheum.090303","article-title":"HLA-DRB1 alleles and rheumatoid arthritis-related pulmonary fibrosis","volume":"37","author":"Migita","year":"2010","journal-title":"J Rheumatol"},{"key":"R69-20250526","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R70-20250526","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R71-20250526","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.40900","article-title":"Malondialdehyde-acetaldehyde adducts and antibody responses in rheumatoid arthritis-associated interstitial lung disease","volume":"71","author":"England","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R72-20250526","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","article-title":"Anticarbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease","volume":"79","author":"Castellanos-Moreira","year":"2020","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:19:52Z","timestamp":1748294392000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000787","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]}}}